✦ LIBER ✦

Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation

✍ Scribed by Matthew Arquette; Todd Wasserman; Ramaswamy Govindan; David Garfield; Neil Senzer; Heidi Gillenwater; Mark Socinski

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 1 study to determine the maximum t

✍ N.C. Choi; J. Hemdon; J. Rosenman; R. Carey; C.T. Chung; S. Bemard; L. Leone; S. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Phase II study of neoadjuvant chemothera

✍ Margaret Deutsch; Jeffrey Crawford; Kenneth Leopold; Walter Wolfe; William Foste 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 939 KB

Phase II study of neoadjuvant chemothera

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Amifostine as mucosal protectant in pati

✍ M Werner-Wasik; C Scott; B Movsas; C Langer; L Sarna; N Nicolaou; R Komaki; M Ma 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 20 KB

Feasibility and toxicity report from a p

✍ Sheikh, H.; Blackhall, F.; Lorigan, P.; Taylor, P.; Ashcroft, L.; Rowbottom, C.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 129 KB

885 Poster Phase I/II study evaluating t

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 144 KB